The Safety and Tolerability of an Aerobic and Resistance Exercise Program With Cognitive Training Post-stroke
- Conditions
- Cerebral Stroke
- Interventions
- Behavioral: CARETBehavioral: Sham CARETBehavioral: Sham CTIBehavioral: CTI
- Registration Number
- NCT02272426
- Lead Sponsor
- University of Miami
- Brief Summary
It is estimated that 2 out of 3 patients with a stroke have some problems with their memory, difficulties performing certain tasks, making decisions and learning new things. In addition, many stroke patients do not get regular exercise and are often sedentary. Both physical and cognitive exercise have the potential to improve quality of life, cognition, and overall health, but the safety and tolerability of such interventions is not clear in stroke patients. The investigators will examine these outcomes by allocating stroke survivor participants to one of two groups: a combined exercise and cognitive training program and a sham control group.
- Detailed Description
Stroke is well recognized as the leading cause of disability in the United States. Cognitive deficits after stroke are common, even in those without dementia prior to the event, and stroke patients with worse cognition on hospital admission have worse outcomes. Cognitive deficits contribute to stroke-related disability and mortality. Evidence suggests an interaction between cognitive deficits and physical limitations, and cognitive rehabilitation may improve functional outcomes post stroke. Recent data also suggest that both cognitive training and exercise interventions improve cognition in stroke patients, but few randomized trials of these interventions, alone or in combination, have been conducted.
We will study the effects of a Combined Aerobic and Resistance Exercise Training (CARET) program and CTI interventions on the primary outcome of safety, feasibility, and adherence among ischemic or hemorrhagic stroke survivors with mild to moderate disability. We hypothesize that these interventions are safe and tolerable, and that they will lead to improvements in our secondary outcomes of cognitive performance and quality of life. We will also explore the role of Brain Derived Neurotrophic Factor in cognitive changes related to the physical exercise intervention.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 132
- Diagnosis of ischemic or hemorrhagic stroke
- Modified Rankin Score (mRS) of <4 at screening
- Recently discharged from the hospital or rehabilitation program
- Male or female ≥18 years of age
- Less than ideal physical activity ≥ 3 months prior to enrollment (less than ideal physical (as defined by the American Heart Association)
- Able to walk ≥10 meters with or without assistance
- Unable to follow instructions for exercise and cognitive interventions
- Any uncontrolled medical condition expected to limit life expectancy or interfere with participation in the trial (i.e. unstable cancer, severe depression or anxiety by the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV) criteria)
- Abnormal stress test, as determined by the treating physician (unless cardiology clearance provided)
- Active substance abuse or alcohol dependence
- Less than 6th grade reading level
- Uncorrected vision or hearing deficits that would preclude administration of the cognitive measures
- Unwilling or unable to provide written informed consent
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description CARET + CTI CARET Combined Aerobic and Resistance Exercise Training (CARET) plus Cognitive Training Intervention (CTI) Sham CARET + Sham CTI Sham CTI Control group Sham Combined Aerobic and Resistance Exercise Training (CARET) plus Sham Cognitive Training Intervention (CTI) CARET + CTI CTI Combined Aerobic and Resistance Exercise Training (CARET) plus Cognitive Training Intervention (CTI) Sham CARET + Sham CTI Sham CARET Control group Sham Combined Aerobic and Resistance Exercise Training (CARET) plus Sham Cognitive Training Intervention (CTI)
- Primary Outcome Measures
Name Time Method Number of participants with treatment emergent serious adverse events At 12 weeks visit (post-intervention) To assess the number of participants with serious adverse events related to the interventions, comparing active groups versus the sham group.
Adherence to a 12-week combined exercise and cognitive training protocol versus a sham group At 12 weeks visit (post-intervention) To assess participant adherence in the intervention group versus the sham group, comparing time on study.
- Secondary Outcome Measures
Name Time Method Change in Cognitive Performance on cognitive neuropsychological battery done at pre, post and 6 month follow-up visits Baseline to 6 months follow up Global cognitive performance will be compared for the intervention groups versus the sham group, using a cognitive assessment battery.
Change in Health Related Quality of Life - Depression Baseline to 6 months follow up measure. As measured by Center for Epidemiologic Studies Depression Scale (CES-D). Minimum score 0, maximum score 60, and a score of 16 or higher indicates clinical depression.
Change in Health Related Quality of Life - Daily Activities Baseline to 6 months follow up As measured by Stroke impact scale scores measuring health related quality of life. Minimum score 16, maximum score 80. Higher scores indicate higher level of functionality in participants, while lower scores indicate a lower level of functionality.
Change in blood plasma concentration of Brain Derived Neurotrophic Factor Baseline to 6 month follow up Brain-derived neurotrophic factor (BDNF) levels will be compared between the exercise group and the sham group at baseline and 12 weeks.
Trial Locations
- Locations (2)
Jackson Memorial Hospital
🇺🇸Miami, Florida, United States
University of Miami Hospital
🇺🇸Miami, Florida, United States